EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 7 filers reported holding EXELIXIS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 11.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,125 | -3.4% | 51,475 | -15.6% | 0.52% | +0.8% |
| Q2 2023 | $1,165 | -2.5% | 60,975 | -1.0% | 0.52% | -5.7% |
| Q1 2023 | $1,195 | +24.2% | 61,575 | +2.7% | 0.55% | +17.9% |
| Q4 2022 | $962 | -99.9% | 59,975 | +5.3% | 0.46% | -0.4% |
| Q3 2022 | $893,000 | -25.5% | 56,975 | -1.0% | 0.46% | -20.4% |
| Q2 2022 | $1,198,000 | -4.4% | 57,535 | +4.1% | 0.58% | +11.7% |
| Q1 2022 | $1,253,000 | – | 55,285 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |